These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23354395)

  • 41. Metabolic derangement in ischemic heart disease and its therapeutic control.
    Ferrari R; Pepi P; Ferrari F; Nesta F; Benigno M; Visioli O
    Am J Cardiol; 1998 Sep; 82(5A):2K-13K. PubMed ID: 9737480
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery.
    Svedjeholm R; Håkanson E; Vanhanen I
    Ann Thorac Surg; 1995 Feb; 59(2 Suppl):S15-22. PubMed ID: 7840694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of ketone bodies in perinatal myocardial energy metabolism.
    Bartelds B; van der Leij FR; Kuipers JR
    Biochem Soc Trans; 2001 May; 29(Pt 2):325-30. PubMed ID: 11356176
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions.
    Calvani M; Reda E; Arrigoni-Martelli E
    Basic Res Cardiol; 2000 Apr; 95(2):75-83. PubMed ID: 10826498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure.
    Seki M; Powers JC; Maruyama S; Zuriaga MA; Wu CL; Kurishima C; Kim L; Johnson J; Poidomani A; Wang T; Muñoz E; Rajan S; Park JY; Walsh K; Recchia FA
    Circ Heart Fail; 2018 Jan; 11(1):e004486. PubMed ID: 29317401
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic therapy of heart failure.
    Fragasso G; Salerno A; Spoladore R; Bassanelli G; Arioli F; Margonato A
    Curr Pharm Des; 2008; 14(25):2582-91. PubMed ID: 18991675
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dichloroacetate as metabolic therapy for myocardial ischemia and failure.
    Bersin RM; Stacpoole PW
    Am Heart J; 1997 Nov; 134(5 Pt 1):841-55. PubMed ID: 9398096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolic causes and prevention of ventricular fibrillation during acute coronary syndromes.
    Oliver MF
    Am J Med; 2002 Mar; 112(4):305-11. PubMed ID: 11893370
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucose Metabolism in Cardiac Hypertrophy and Heart Failure.
    Tran DH; Wang ZV
    J Am Heart Assoc; 2019 Jun; 8(12):e012673. PubMed ID: 31185774
    [No Abstract]   [Full Text] [Related]  

  • 50. Cardiac fatty acid metabolism and ischemic memory imaging with nuclear medicine techniques.
    Palaniswamy SS; Padma S
    Nucl Med Commun; 2011 Aug; 32(8):672-7. PubMed ID: 21606884
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ischemia and reperfusion injury in the hypertrophied heart.
    Allard MF; Lopaschuk GD
    EXS; 1996; 76():423-41. PubMed ID: 8805809
    [No Abstract]   [Full Text] [Related]  

  • 52. A study on dilazep: I. Mechanism of anti-ischemic action of dilazep is not coronary vasodilation but decreased cardiac mechanical function in the isolated, working rat heart.
    Hoque AN; Hoque N; Hashizume H; Abiko Y
    Jpn J Pharmacol; 1995 Mar; 67(3):225-32. PubMed ID: 7630040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Imaging myocardial metabolism and ischemic memory.
    Taegtmeyer H; Dilsizian V
    Nat Clin Pract Cardiovasc Med; 2008 Aug; 5 Suppl 2():S42-8. PubMed ID: 18641606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging of myocardial metabolism by positron emission tomography.
    Rigo P; de Landsheere C; Melon P; Kulbertus H
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 4():847-51. PubMed ID: 2093380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modulation of cardiac metabolism during myocardial ischemia.
    Chagas AC; Dourado PM; Galvão Tde F
    Curr Pharm Des; 2008; 14(25):2563-71. PubMed ID: 18991673
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myocardial reloading after extracorporeal membrane oxygenation alters substrate metabolism while promoting protein synthesis.
    Kajimoto M; O'Kelly Priddy CM; Ledee DR; Xu C; Isern N; Olson AK; Des Rosiers C; Portman MA
    J Am Heart Assoc; 2013 Aug; 2(4):e000106. PubMed ID: 23959443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Midazolam's effects on myocardial load and coronary perfusion: reduced regional O2 consumption and lactate production during ischemia in dogs.
    Sidi A; Rush W
    J Cardiothorac Vasc Anesth; 1994 Jun; 8(3):302-9. PubMed ID: 8061264
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of low-flow ischemia on substrate oxidation and glycolysis in the isolated perfused rat heart.
    Lloyd SG; Wang P; Zeng H; Chatham JC
    Am J Physiol Heart Circ Physiol; 2004 Jul; 287(1):H351-62. PubMed ID: 15001444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?
    van Bilsen M; Smeets PJ; Gilde AJ; van der Vusse GJ
    Cardiovasc Res; 2004 Feb; 61(2):218-26. PubMed ID: 14736538
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function.
    Pepe S; McLennan PL
    Circulation; 2002 May; 105(19):2303-8. PubMed ID: 12010914
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.